Impact of Pharmaceutical care in heart failure patients
Not Applicable
- Conditions
- Health Condition 1: I501- Left ventricular failure, unspecified
- Registration Number
- CTRI/2022/10/046436
- Lead Sponsor
- Dr Anu Philip
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Heart failure patients with reduced ejection fraction (EF �40%, who are hemodynamically stable).
Exclusion Criteria
Patients who are not willing to participate in the study.
Patients diagnosed with-
1) Cancer
2) Psychiatric disorder
3) Immuno-compromised patients
4) critically ill patients
5) Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improve Health Related Quality of LifeTimepoint: 1 year(baseline, 6th month, and 12th month assessment)
- Secondary Outcome Measures
Name Time Method Medication adherence, clinical and economic outcomesTimepoint: 1 year(baseline, 6th month, and 12th month assessment)